A Study of ZG005 in Patients With Advanced Solid Tumors
Clinical trial NCT06233292 · UNKNOWN
Trial details
- NCT number
- NCT06233292
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-17
- Primary completion
- 2026-01-01
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.